Search Results - "Reilly, C F"

Soluble Cell Adhesion Molecules in Hypertriglyceridemia and Potential Significance on Monocyte Adhesion by Abe, Yasunori, El-Masri, Bassem, Kimball, Kay T, Pownall, Henry, Reilly, Christopher F, Osmundsen, Karin, Smith, C. Wayne, Ballantyne, Christie M

“…Hypertriglyceridemia may contribute to the development of atherosclerosis by increasing expression of cell adhesion molecules (CAMs). Although the cellular…”
Get full text

Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells by REILLY, C. F, MCFALL, R. C

“…Bovine vascular smooth muscle cells (SMC) were examined for production of plasminogen activator inhibitor-1 (PAI-1) which may play a key role in regulating the…”
Get full text

Heparin Prevents Vascular Smooth Muscle Cell Progression through the G1 Phase of the Cell Cycle by Reilly, C F, Kindy, M S, Brown, K E, Rosenberg, R D, Sonenshein, G E

“…To gain insight into the mechanism of the antiproliferative effects of heparin on vascular smooth muscle cells (SMC), the influence of this glycosaminoglycan…”
Get full text

An Antiproliferative Heparan Sulfate Species Produced by Postconfluent Smooth Muscle Cells by Linda M. S. Fritze, Reilly, Christopher F., Rosenberg, Robert D.

“…Heparan sulfate was isolated from the cell surface, cell pellet, and culture medium of exponentially growing as well as postconfluent bovine aortic smooth…”
Get full text

Plasminogen activator inhibitor-1 binds to fibrin and inhibits tissue-type plasminogen activator-mediated fibrin dissolution by REILLY, C. F, HUTZELMANN, J. E

“…Plasminogen activator inhibitor-1 (PAI-1) accumulates within thrombi and forming whole blood clots. To explore this phenomenon at the molecular level, PAI-1…”
Get full text

Variables in skin preparations may make comparison of antiseptics difficult by Reilly, F C

Get more information

Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides by Connolly, T M, Condra, C, Feng, D M, Cook, J J, Stranieri, M T, Reilly, C F, Nutt, R F, Gould, R J

“…The aggregation of platelets from a variety of animal species in response to thrombin receptor-derived activating peptides was evaluated. A series of…”
Get more information

Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases by Reilly, C F, Tewksbury, D A, Schechter, N M, Travis, J

“…Human neutrophil cathepsin G and human skin mast cell chymase rapidly convert angiotensin I to angiotensin II with only minor cleavage elsewhere in the…”
Get full text

Noninvasive 3-D ultrasound of atherosclerotic plaques in the Watanabe rabbit by Allott, C P, Barry, C D, Bramley, J, John, N W, Mellor, P M, Thomson, D S, Reilly, C F

“…We have investigated the ability to quantitate atherosclerosis in the aortic arch of the Watanabe rabbit using noninvasive 3-D ultrasound. Our methodology…”
Get more information

Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosis by HUCKLE, W. R, DRAG, M. D, MANTLO, N. B, CHANG, R. S. L, REILLY, C. F, SCHWARTZ, R. S, GREENLEE, W. J, JOHNSON, R. G, ACKER, W. R, POWERS, M, MCFALL, R. C, HOLDER, D. J, FUJITA, T, STABILITO, I. I, DOOSEOP KIM, ONDEYKA, D. L

“…Numerous studies have demonstrated the ability of angiotensin II (Ang II) receptor antagonists and angiotensin-converting enzyme (ACE) inhibitors to inhibit…”
Get full text

The inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1. The effects of fibrinogen, heparin, vitronectin, and lipoprotein(a) by Edelberg, J M, Reilly, C F, Pizzo, S V

“…Plasminogen activator inhibitor-1 (PAI-1) regulates fibrinolysis by inhibiting tissue type plasminogen activator (t-PA). Fibrinogen, heparin, and vitronectin…”
Get full text

Suppression of thrombolysis in a canine model of pulmonary embolism by MARSH, J. J, KONOPKA, R. G, LANG, I. M, HUAN-YOU WANG, PEDERSEN, C, CHILES, P, REILLY, C. F, MOSER, K. M

“…The brisk fibrinolytic response of canines has impaired efforts to develop a canine model of chronic thromboembolic pulmonary hypertension. Difficulties in…”
Get full text

Inflammatory mechanisms in atherosclerosis, Glaxo-Wellcome Medicines Research Centre, Stevenage, Herts, UK, 3rd July 1995 by Black, D, Reilly, C F

Get full text

Estimation of 7-day, 10-year low-streamflow statistics using baseflow correlation by Reilly, Christine F., Kroll, Charles N.

“…Estimators of low‐streamflow statistics are often required for water quality and quantity management at gauged and ungauged sites. Here the technique of…”
Get full text

Heparin inhibition of smooth muscle cell proliferation: a cellular site of action by Reilly, C F, Fritze, L M, Rosenberg, R D

“…The potential of a given amount of heparin to inhibit smooth muscle cell (SMC) proliferation can be increased more than 13 fold if quiescent cultures are…”
Get more information

Plasminogen activator inhibitor-1 suppresses endogenous fibrinolysis in a canine model of pulmonary embolism by REILLY, C. F, FUJITA, T, HUTZELMANN, J. E, MAYER, E. J, SHEBUSKI, R. J

“…Plasminogen activator inhibitor-1 (PAI-1), the specific, fast-acting inhibitor of tissue-type plasminogen activator (t-PA), binds to fibrin and has been found…”
Get full text

Both circulating and clot-bound plasminogen activator inhibitor-1 inhibit endogenous fibrinolysis in the rat by Reilly, C F, Fujita, T, Mayer, E J, Siegfried, M E

“…The effects of both clot-bound and circulating plasminogen activator inhibitor-1 (PAI-1) on endogenous fibrinolysis were investigated in a rat model of…”
Get full text

Thrombin receptor agonist peptide induction of mitogenesis in CCL39 cells by Reilly, C F, Connolly, T M, Feng, D M, Nutt, R F, Mayer, E J

“…The role of the thrombin receptor tethered ligand hypothesis in mediating the mitogenic responses of cells to thrombin was explored. We have found that small…”
Get more information

The Pharmacokinetics of Plasminogen Activator Inhibitor-1 in the Rabbit by Mayer, Ernest J., Fujita, Tsuneo, Gardell, Stephen J., Shebuski, Ronald J., Reilly, Christopher F.

“…The pharmacokinetics of the activated and latent forms of plasminogen activator inhibitor-1 (PAI-1) isolated from HT1080 fibrosarcoma cells (HT1080 PAI-1) and…”
Get full text

Differential effects of PDGF and PDGF-BB on vascular smooth muscle cells by Reilly, C F, Broski, J E

“…Several biological effects of recombinant PDGF-BB and PDGF obtained from human platelets were examined with vascular smooth muscle cells. Although PDGF and…”
Get more information